@misc{indiciae1ceca72340f5,
  title = {The MS remyelinating drug bexarotene (an RXR agonist) promotes induction of human Tregs and suppresses Th17 differentiation in vitro},
  author = {Gaunt, C. M. and Rainbow, D. and MacKenzie, R. and Jarvis, L. and Mousa, H. and Cunniffe, N. and Georgieva, Z. and Brown, W. and Coles, A. and Jones, J. L.},
  year = {2021},
  doi = {10.1101/2021.02.17.431344},
  url = {https://www.biorxiv.org/content/10.1101/2021.02.17.431344v1},
  note = {Source identifier: 10.1101/2021.02.17.431344}
}